Journal of Yeungnam Medical Science

Original articles

Surgery
Health system disruption and oncologic consequences: a retrospective observational study of South Korea’s 2024 medical walkout: Seung Ho Song, Chang Hyun Kim, Soo Yeun Park; J Yeungnam Med Sci. 2026;43:4. Published online December 18, 2025; DOI: https://doi.org/10.12701/jyms.2026.43.4

1,625 View
29 Download

Abstract PDF Supplementary Material: Background
In February 2024, a sudden government policy to drastically increase medical school admissions triggered the mass resignations of medical trainees across South Korea, severely disrupting hospital operations. This study aimed to evaluate the impact of the resulting healthcare workforce disruptions on short-term clinical outcomes and the timing of colorectal cancer surgeries.
Methods
This retrospective comparative study analyzed patients with colorectal cancer treated at two national university hospitals in Daegu and Gwangju, South Korea. Patients who first visited the colorectal surgery department between March and August of 2023 and 2024 were included. Data from 2020 to 2022 were used for extended comparisons. The primary outcome was the interval from initial outpatient visit to surgery. Secondary outcomes included treatment modality distribution, tumor staging, and postoperative complications.
Results
A total of 895 patients in 2023 and 853 in 2024 were included. In 2024, only 39.5% of patients (337/853) underwent upfront surgery compared to 63.5% (569/895) in 2023. The median time to surgery increased from 30 days (interquartile range [IQR], 22–44 days) to 52 days (IQR, 30–72 days) (p=0.001). Clinical T3–4 tumors increased from 49.9% to 59.3% (p=0.018), lymph node-positive cases increased from 25.9% to 51.3% (p=0.001), and postoperative complication rates increased from 12.0% to 28.2% (p=0.001).
Conclusion
The abrupt healthcare workforce crisis in early 2024 significantly delayed colorectal cancer surgeries and was associated with worse short-term oncologic outcomes. These findings highlight the critical importance of maintaining a stable healthcare workforce to protect access to timely cancer care.

Anesthesiology and Pain Medicine
Comparison of the protective effects of infliximab and splenectomy on hepatic ischemia-reperfusion injury in rats: an experimental study: Shiback Lee, Deokhee Lee, Youngjun Jang, Dong Gun Lim, Kyung Hwa Kwak, Hoon Jung, Eun Kyung Choi; J Yeungnam Med Sci. 2025;42:72. Published online November 10, 2025; DOI: https://doi.org/10.12701/jyms.2025.42.72

731 View
43 Download

Abstract PDF: Background
Hepatic ischemia-reperfusion injury (IRI) is a complex process involving multiple mediators that initiate inflammatory responses, ultimately leading to cell necrosis and apoptosis. During hepatic IRI, various inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), and reactive oxygen species (ROS) exacerbate liver injury. Infliximab is an antibody that neutralizes TNF-α, and suppression of TNF-α activity with infliximab treatment can protect the liver from IRI. Splenectomy also alleviates hepatic IRI by decreasing neutrophil infiltration, reducing the release of ROS into the hepatic sinusoids, and suppressing TNF-α release. This study aimed to evaluate the effects of infliximab on hepatic IRI based on inflammatory responses, oxidative stress, and apoptosis, and to compare these effects with those of splenectomy.
Methods
Twenty-four rats were randomly assigned to the following four groups: (1) sham, (2) hepatic ischemia-reperfusion (IR), (3) hepatic IR with 10 mg/kg infliximab, and (4) hepatic IR with splenectomy. Each group consisted of six rats. Hepatic ischemia was induced for 30 minutes, followed by 2 hours of reperfusion injury. Infliximab was administered intraperitoneally 1 hour before surgery and splenectomy was performed immediately before hepatic ischemia.
Results
Infliximab and splenectomy downregulated the levels of liver enzymes (aspartate aminotransferase [p<0.001 for all] and alanine aminotransferase [p<0.001 for all]), a prooxidant (malondialdehyde [p=0.006 for infliximab; p<0.001 for splenectomy]), inflammatory cytokines (TNF-α and nuclear factor kappa B [p<0.001 for all]), and an apoptotic mediator (caspase-3 [p=0.005 for infliximab; p=0.004 for splenectomy]) compared with those with hepatic IR alone.
Conclusion
Infliximab treatment and splenectomy mitigated hepatic IRI. These protective effects are likely mediated via anti-inflammatory, antioxidative, and antiapoptotic pathways within the pathophysiology of hepatic IRI.

Focused Review article

Gastroenterology and Hepatology
Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review: Jong Ryeol Eun; J Yeungnam Med Sci. 2025;42:3. Published online November 11, 2024; DOI: https://doi.org/10.12701/jyms.2024.01088

7,494 View
143 Download
1 Web of Science

Abstract PDF: Hepatocellular carcinoma (HCC) accounts for 85% to 90% of primary liver cancers and generally has a poor prognosis. The hierarchical model, which posits that HCC originates from liver cancer stem cells (CSCs), is now widely accepted, as it is for other cancer types. As CSCs typically reside in the G0 phase of the cell cycle, they are resistant to conventional chemotherapy. Therefore, to effectively treat HCC, developing therapeutic strategies that target liver CSCs is essential. Clinically, HCCs exhibit a broad spectrum of pathological and clinical characteristics, ranging from well-differentiated to poorly differentiated forms, and from slow-growing tumors to aggressive ones with significant metastatic potential. Some patients with HCC also show features of cholangiocarcinoma. This HCC heterogeneity may arise from the diverse cellular origins of liver CSCs. This review explores the normal physiology of liver regeneration and provides a comprehensive overview of hepatocarcinogenesis, including cancer initiation, isolation of liver CSCs, molecular signaling pathways, and microRNAs. Additionally, the cellular origins of liver CSCs are reviewed, emphasizing hematopoietic and mesenchymal stem cells, along with the well-known hepatocytes and hepatic progenitor cells.

Original articles

Gastroenterology and Hepatology
Association between total body muscle percentage and prevalence of non-alcoholic fatty liver disease in Korean adults findings from an 18-year follow-up: a prospective cohort study: Byoung Chan Ahn, Chul Yong Park, Jung Hee Hong, Ki Ook Baek; J Yeungnam Med Sci. 2023;40(Suppl):S47-S55. Published online August 29, 2023; DOI: https://doi.org/10.12701/jyms.2023.00605

5,223 View
66 Download

Abstract PDF Supplementary Material: Background
This study aimed to elucidate the association between total lean muscle mass and the incidence of non-alcoholic fatty liver disease (NAFLD) in the adult Korean population.
Methods
Utilizing data derived from the 18-year prospective cohort of the Korean Genome and Epidemiology Study, NAFLD was diagnosed via the hepatic steatosis index with an established cutoff value of 36. Lean muscle mass was assessed via bioelectrical impedance analysis and subsequently divided into tertiles. A generalized mixed model with a logit link was employed for repeated measures data analysis, accounting for potential confounders.
Results
Analysis encompassed 7,794 participants yielding 49,177 measurements. The findings revealed a markedly increased incidence of NAFLD in the lower tertiles of muscle mass, specifically, tertile 1 (odds ratio [OR], 20.65; 95% confidence interval [CI], 9.66–44.11) and tertile 2 (OR, 4.57; 95% CI, 2.11–9.91), in comparison to tertile 3. Age-dependent decreases in the OR were observed within the tertile 1 group, with ORs of 10.12 at age of 40 years and 4.96 at age of 80 years. Moreover, each 1%-point increment in total muscle mass corresponded with an estimated OR of 0.87 (95% CI, 0.82–0.93) for NAFLD resolution.
Conclusions
The study demonstrates a significant association between total muscle mass and NAFLD prevalence among Korean adults. Given the potential endocrine role of muscle mass in NAFLD pathogenesis, interventions aimed at enhancing muscle mass might serve as an effective public health strategy for mitigating NAFLD prevalence.

Otorhinolaryngology
Association between fatty liver disease and hearing impairment in Korean adults: a retrospective cross-sectional study: Da Jung Jung; J Yeungnam Med Sci. 2023;40(4):402-411. Published online June 26, 2023; DOI: https://doi.org/10.12701/jyms.2023.00304

14,303 View
80 Download
5 Web of Science
7 Crossref

Abstract PDF

Background
We hypothesized that fatty liver disease (FLD) is associated with a high prevalence of hearing loss (HL) owing to metabolic disturbances. This study aimed to evaluate the association between FLD and HL in a large sample of the Korean population.
Methods
We used a dataset of adults who underwent routine voluntary health checkups (n=21,316). Fatty liver index (FLI) was calculated using Bedogni’s equation. The patients were divided into two groups: the non-FLD (NFLD) group (n=18,518, FLI <60) and the FLD group (n=2,798, FLI ≥60). Hearing thresholds were measured using an automatic audiometer. The average hearing threshold (AHT) was calculated as the pure-tone average at four frequencies (0.5, 1, 2, and 3 kHz). HL was defined as an AHT of >40 dB.
Results
HL was observed in 1,370 (7.4%) and 238 patients (8.5%) in the NFLD and FLD groups, respectively (p=0.041). Compared with the NFLD group, the odds ratio for HL in the FLD group was 1.16 (p=0.040) and 1.46 (p<0.001) in univariate and multivariate logistic regression analyses, respectively. Linear regression analyses revealed that FLI was positively associated with AHT in both univariate and multivariate analyses. Analyses using a propensity score-matched cohort showed trends similar to those using the total cohort.
Conclusion
FLD and FLI were associated with poor hearing thresholds and HL. Therefore, active monitoring of hearing impairment in patients with FLD may be helpful for early diagnosis and treatment of HL in the general population.

Citations

Citations to this article as recorded by

Repurposing Renin–Angiotensin System Drugs for the Treatment of Audiovestibular Disorders
Grant Podhajsky, Kiran S. Marla, Alec P. Marticoff, Kenny Nguyen, Tanner Kempton, Sepehr Salehpour, Caden Duffy, Douglas M. Bennion
Journal of Clinical Medicine.2026; 15(2): 743. CrossRef
Metabolic-dysfunction-associated steatohepatitis impairs cochlear integrity and delays auditory recovery after noise trauma
Sheng Jin, Soo Jeong Kim, Ah-Ra Lyu, Sun-Ae Shin, Tae Hwan Kim, Long Jin, Jun Young Heo, Min Jung Park, Yong-Ho Park
Cell Communication and Signaling.2026;[Epub] CrossRef
Association of Metabolic Dysfunction‐Associated Steatotic Liver Disease With Sudden Sensorineural Hearing Loss Among Older Adults
Eun Seok Kang, Seohui Jang, Hye Jun Kim, Kyuwoong Kim, Meng Sha, Yun Hwan Oh, Michelle J. Suh, Seogsong Jeong
Laryngoscope Investigative Otolaryngology.2025;[Epub] CrossRef
A Higher Liver Fibrosis-4 Index Is Associated With More Severe Hearing Loss in Idiopathic Sudden Sensorineural Hearing Loss
Yukihide Maeda, Soshi Takao, Ryotaro Omichi, Mizuo Ando
Cureus.2025;[Epub] CrossRef
Multifactorial Analysis of Congenital Hearing Loss: Demographic, Hematological, and Biochemical Perspectives
Lucky Thakkar, Manjunath Dandinarasaiah, Shubhangi Pingle, S. Veeresh, Suresh Basavaraj Arakera
Journal of the Scientific Society.2025; 52(3): 213. CrossRef
The inflammatory and metabolic status of patients with sudden-onset sensorineural hearing loss
Jônatas Bussador do Amaral, Kelly Abdo Peron, Tracy Lima Tavares Soeiro, Marina Cançado Passarelli Scott, Flávia Tatiana Pedrolo Hortense, Michelly Damasceno da Silva, Carolina Nunes França, Luiz Henrique da Silva Nali, André Luis Lacerda Bachi, Norma de
Frontiers in Neurology.2024;[Epub] CrossRef
Which Environmental Pollutants Are Toxic to Our Ears?—Evidence of the Ototoxicity of Common Substances
Gregory M. Zarus, Patricia Ruiz, Rae Benedict, Stephan Brenner, Krystin Carlson, Layna Jeong, Thais C. Morata
Toxics.2024; 12(9): 650. CrossRef

Review article

Radiology, Radiotherapy & Diagnostic Imaging
Hepatic encephalopathy on magnetic resonance imaging and its uncertain differential diagnoses: a narrative review: Chun Geun Lim, Myong Hun Hahm, Hui Joong Lee; J Yeungnam Med Sci. 2023;40(2):136-145. Published online January 10, 2023; DOI: https://doi.org/10.12701/jyms.2022.00689

18,074 View
427 Download
9 Web of Science
13 Crossref

Abstract PDF

Hepatic encephalopathy (HE) is a severe neuropsychiatric abnormality in patients with either acute or chronic liver failure. Typical brain magnetic resonance imaging findings of HE are bilateral basal ganglia high signal intensities due to manganese deposition in chronic liver disease and hyperintensity in T2, fluid-attenuated inversion recovery, or diffusion-weighted imaging (DWI) with hemispheric white matter changes including the corticospinal tract. Low values on apparent diffusion coefficient mapping of the affected area on DWI, indicating cytotoxic edema, can be observed in acute HE. However, neuropsychological impairment in HE ranges from mild deficits in psychomotor abilities affecting quality of life to stupor or coma with higher grades of hepatic dysfunction. In particular, the long-lasting compensatory mechanisms for the altered metabolism in chronic liver disease make HE imaging results variable. Therefore, the clinical relevance of imaging findings is uncertain and differentiating HE from other metabolic diseases can be difficult. The recent introduction of concepts such as “acute-on-chronic liver failure (ACLF),” a new clinical entity, has led to a change in the clinical view of HE. Accordingly, there is a need to establish a corresponding concept in the field of neuroimaging diagnosis. Herein, we review HE from a historical and etiological perspective to increase understanding of brain imaging and help establish an imaging approach for advanced new concepts such as ACLF. The purpose of this manuscript is to provide an understanding of HE by reviewing neuroimaging findings based on pathological and clinical concepts of HE, thereby assisting in neuroimaging interpretation.

Citations

Citations to this article as recorded by

Correlation Between Brain MRI Findings and Serum Ammonia Levels in Hepatic Encephalopathy
Muhammad Fahad Atta, Maria Irum, Sumaira Aslam, Naima Mujahid, Khawar Anwar, Shabzain Ishrat
Pakistan Journal of Health Sciences.2026; : 14. CrossRef
“Two birds talking” and “monkey face” Sign in hepatic encephalopathy
Qian Zheng, Jifen Wang
Acta Neurologica Belgica.2026;[Epub] CrossRef
Hepatic Encephalopathy Classification via Neuro-livo Features-Based Deep Tri-path Fused Neural Network
R. K. Shanmugha Priya, K. Suthendran
International Journal of Computational Intelligence Systems.2025;[Epub] CrossRef
Cell–cell communications in the brain of hepatic encephalopathy: The neurovascular unit
Kyuwan Choi, Yena Cho, Yerin Chae, So Yeong Cheon
Life Sciences.2025; 363: 123413. CrossRef
A Case of Hepatic Encephalopathy With Diffuse Brainstem Signal Changes on Magnetic Resonance Imaging
Hiromu Yurimoto, Taiki Matsubayashi, Isamu Shibata, Misako Furuki, Masato Obayashi
Cureus.2025;[Epub] CrossRef
Brain Changes in Alcohol Induced Liver Cirrhosis Patients: Insights from Quantitative Susceptibility Mapping
Andrej Vovk, Stefan Ropele, Sebastian Stefanovic, Borut Stabuc, Dusan Suput, Marjana Turk Jerovsek, Gasper Zupan
Biomedicines.2025; 13(12): 2937. CrossRef
Pattern Clustering of Symmetric Regional Cerebral Edema on Brain MRI in Patients with Hepatic Encephalopathy
Chun Geun Lim, Hui Joong Lee
Journal of the Korean Society of Radiology.2024; 85(2): 381. CrossRef
Response to “Brain Lesions in Liver Cirrhosis May Not Only Be Due to Hepatic Encephalopathy”
Hui Joong Lee
Journal of the Korean Society of Radiology.2024; 85(4): 827. CrossRef
Altered Mental Status in the Solid-Organ Transplant Recipient
Nicolas Weiss, Henning Pflugrad, Prem Kandiah
Seminars in Neurology.2024; 44(06): 670. CrossRef
Reversibility of structural and functional alterations of hepatic encephalopathy
Henning Pflugrad, Ann-Katrin Hennemann
Metabolic Brain Disease.2024;[Epub] CrossRef
Rule out all differential causes before attributing cerebral bleeding to 5-aminolevulinic acid
Josef Finsterer, Sounira Mehri
Child's Nervous System.2023; 39(4): 847. CrossRef
Minimal hepatic encephalopathy: clinical, neurophysiological, neuroimaging markers
P. I. Kuznetsova, A. A. Raskurazhev, S. N. Morozova, I. M. Lovchev, M. S. Novruzbekov, M. M. Tanashyan
Russian neurological journal.2023; 28(5): 21. CrossRef
Prevalence of Precipitating Factors of Hepatic Encephalopathy at Nangarhar Regional Hospital
Ameerullah Razai, Ismail Khan Safi, Said Abdul Jamil Saidi, Said Inam Saidi
Nangarhar University International Journal of Biosciences.2023; : 34. CrossRef

Case report

Internal Medicine
Thallium poisoning: a case report: Oscar Jimenez, Hector Cáceres, Luis Gimenez, Luciana Soto, Micaela Montenegro, Jhon Alexander Avila Rueda; J Yeungnam Med Sci. 2023;40(3):311-314. Published online December 15, 2022; DOI: https://doi.org/10.12701/jyms.2022.00647

28,014 View
259 Download
8 Web of Science
4 Crossref

Abstract PDF

Thallium poisoning is usually accidental. We present a case of a 51-year-old woman who was evaluated in June 2018 for myalgia, vertigo, asthenia, and abdominal pain. Physical examination revealed temporal-spatial disorientation, jaundice, and asterixis. The laboratory reported the following: bilirubin, 10.3 mg/dL; aspartate transaminase, 78 U/L; alanine transaminase, 194 U/L; albumin, 2.3 g/dL; prothrombin time, 40%; and platelet count, 60,000/mm3. Serology performed for hepatitis A, B, and C; Epstein-Barr virus; cytomegalovirus; and human immunodeficiency virus was negative, and a collagenogram was negative. Physical reevaluation revealed alopecia on the scalp, armpits, and eyebrows; macules on the face; plantar hyperkeratosis; and ulcers on the lower limbs. Tests for lead, arsenic, copper, and mercury were carried out, which were normal; however, elevated urinary thallium (540 µg/g; range, 0.4–10 µg/g) was observed. The patient was treated with ᴅ-penicillamine 1,000 mg/day and recovered her urinary thallium levels were within normal range at annual follow-up. Thallium poisoning is extremely rare and can be fatal in small doses. An adequate clinical approach can facilitate early diagnosis.

Citations

Citations to this article as recorded by

Movement disorders associated with diarrhoea
Claudia Lazcano-Ocampo, Tobias Warnecke, Iro Boura, Daniele Urso, Valentina Leta, Karolina Poplawska-Domaszewicz, Lucia Batzu, Ece Bayram, Vanessa Raeder, Chin-Hsien Lin, Cristian Falup-Pecurariu, K. Ray Chaudhuri
Journal of Neural Transmission.2026; 133(1): 15. CrossRef
Thallium distribution along segmented single hairs in a case of a criminal poisoning
Peter Heitland, Fritz Pragst, Sven Hartwig, Helmut D Köster
Journal of Analytical Toxicology.2025; 49(7): 492. CrossRef
Thallium reabsorption via NKCC2 causes severe acute kidney injury with outer medulla-specific calcium crystal casts in rats
Kana Unuma, Shuheng Wen, Sho Sugahara, Shutaro Nagano, Toshihiko Aki, Tadayuki Ogawa, Shino Takeda-Homma, Masakazu Oikawa, Akihiro Tojo
Archives of Toxicology.2024; 98(12): 3973. CrossRef
Іmprovement of the differential diagnostics of acute oral and inhalation poisoning by thalium compounds, pathohistology and treatment strategy (based on group cases)
G.M. Balan, B.S. Sheyman, P.G. Zhminko, D.O. Dziuba, O.N. Rozhkova, N.V. Kurdil, A.H. Kudriavtseva, V.S. Lisovska, N.P. Chermnykh
Ukrainian Journal of Modern Toxicological Aspects.2023; 95(2): 66. CrossRef

Review article

Anesthesiology and Pain Medicine
Hepatic ischemia-reperfusion injury with respect to oxidative stress and inflammatory response: a narrative review: Eun Kyung Choi, Dong Gun Lim; J Yeungnam Med Sci. 2023;40(2):115-122. Published online March 21, 2022; DOI: https://doi.org/10.12701/jyms.2022.00017

13,319 View
187 Download
32 Web of Science
32 Crossref

Abstract PDF

Hepatic ischemia-reperfusion injury is a major complication of liver transplantation, trauma, and shock. This pathological condition can lead to graft dysfunction and rejection in the field of liver transplantation and clinical hepatic dysfunction with increased mortality. Although the pathological mechanisms of hepatic ischemia-reperfusion injury are very complex, and several intermediators and cells are involved in this phenomenon, oxidative stress and inflammatory responses are the key processes that aggravate hepatic injury. This review summarizes the current understanding of oxidative stress and inflammatory responses and, in that respect, addresses the therapeutic approaches to attenuate hepatic ischemia-reperfusion injury.

Citations

Citations to this article as recorded by

Role of Histamine in Liver Ischemia-Reperfusion Injury—Implication for H1 Receptor Antagonist in the Clinical Application
Hiroshi Kawamoto, Yoichiro Uchida, Hirofumi Hirao, Kenichi Saga, Junya Kawasoe, Kentaro Kadono, Masaaki Ito, Yuki Kidoguchi, Kosuke Tanaka, Shoichi Kageyama, Kojiro Nakamura, Kojiro Taura, Hiroaki Terajima, Takeshi Watanabe, Etsuro Hatano
Transplantation.2026; 110(3): e583. CrossRef
Pathological mechanisms of hepatic ischemia-reperfusion injury and stem cell–based therapeutic strategies: Mechanistic insights and translational perspectives
Ru Nie, Yunlong Duan, Xiaoting Cao, Mingquan Pang, Zhixin Wang, Haining Fan
Pathology - Research and Practice.2026; 280: 156382. CrossRef
Indicaxanthin Mitigates Hepatic Ischemia Reperfusion Injury in Rats via Bax/Bcl‐2 Modulation: Experimental Evidence Supported by Molecular Docking and Dynamics Simulation
Mahmoud Abdelnaser, Abeer H. Elmaidomy, Mina Ezzat Attya, Faisal H. Altemani, Naseh A. Algehainy, Mohammad A. Alanazi, Abdullah H. Altemani, Usama Ramadan Abdelmohsen
Archiv der Pharmazie.2026;[Epub] CrossRef
The Mechanism of G Protein-Coupled Receptor Regulation of Ferroptosis in Hepatic Ischemia–Reperfusion Injury
Die Hu, Lei Sun, Mei Su, Xuekun Xing
International Journal of Molecular Sciences.2026; 27(6): 2866. CrossRef
Protective effect of irbesartan against hepatic ischemia–reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats
Salma A. El-Marasy, Rasha E. Mostafa, Hoda B. Mabrok, Marwa S. Khattab, Sally A. El Awdan
Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(2): 1681. CrossRef
Repurposing the antimalarial chloroquine: a potential therapy for hepatic injury in a rat model of hindlimb ischemia–reperfusion by modulating apoptosis, autophagy, inflammation, and oxidative stress
Miar M. Sherif, Hanan S. El-Abhar, Hala M. Fawzy, Amany M. Gad, Dalaal M. Abdallah
Future Journal of Pharmaceutical Sciences.2025;[Epub] CrossRef
HSYA from safflower mitigates oxidative stress, inflammation, and apoptosis in liver ischemia-reperfusion injury
Jianhua Liao, Chunyan Meng, Jun Cheng, Baoqing Liu, Yuzhi Shao
Xenobiotica.2025; 55(3): 239. CrossRef
Development and validation of a predictive model for postoperative hepatic dysfunction in Stanford type A aortic dissection
Xiaotian Han, Wei Wang, Tianxiang Gu, Enyi Shi
Scientific Reports.2025;[Epub] CrossRef
Exosomes derived from ALR-modified adipose mesenchymal stem cells mediate hepatoprotective effects on hepatic ischemia–reperfusion injury by promoting regeneration and protecting mitochondria
YaJun Ma, Tao Liu, Pujun Li, Lei Cao, Xiangyu Lu, HongBin Wang
Stem Cell Research & Therapy.2025;[Epub] CrossRef
Hepatic ischemia-reperfusion and mitochondrial quality control: potential therapeutic targets
Junqi Wang, Wenkai Fu, Nan Lu, Zhijiang Guo, Ong Sang Bing, Hongshuo Shi, Hao Zhou, Xing Chang, Miao Meng
International Immunopharmacology.2025; 163: 115267. CrossRef
In Vivo Monitoring of Hepatic Ischemia Using a Dual-Enzyme Activated Near-Infrared Fluorescence Probe
So Jin Hong, Hoseo Lee, Eui Jin Lee, Minseol Kim, Ho Jae Ryu, Ja Hyun Koo, Min Hee Lee
ACS Sensors.2025; 10(8): 6074. CrossRef
Lycopene Ameliorates Hepatic Ischemia‐Reperfusion Injury in Rats by Suppressing HRD1 E3 Ubiquitin Ligase to Restore Nrf2 Signaling
Li Li, Hui Zhang, Yuchao Sun, Ignazio Restivo
Journal of Food Biochemistry.2025;[Epub] CrossRef
NADPH Oxidase: A Potential Therapeutic Target to Reduce Primary Sclerosis Cholangitis Following Liver Transplantation
Mohsen Aliakbarian, Kiarash Ashrafzadeh, Gordon A. Ferns, Reyhaneh Hadian, Rozita Khodashahi, Mohammad-Hassan Arjmand
Current Medicinal Chemistry.2025; 32(38): 8598. CrossRef
Novel Perspectives in Hepatic Ischemia-Reperfusion Injury: The cGAS-STING Pathway
Runsheng Chen, Tingfeng Yang, Zhonghao Jiang, Yang Long, Baolin Qian, Wenguang Fu
Journal of Inflammation Research.2025; Volume 18: 16427. CrossRef
Comparative Investigation of the Effects of Adenosine Triphosphate, Melatonin, and Thiamine Pyrophosphate on Amiodarone-Induced Neuropathy and Neuropathic Pain in Male Rats
Agah Abdullah Kahramanlar, Habip Burak Ozgodek, Ramazan Ince, Bulent Yavuzer, Ozlem Admis, Ali Sefa Mendil, Bilge Ekinci, Halis Suleyman
Biomedicines.2025; 13(12): 2965. CrossRef
Bavachalcone Protects Against Acetaminophen‐Induced Acute Liver Toxicity in Mice by Inhibiting Inflammation and Oxidative Stress Responses
Tian Liu, Songlan Sui, Hua An, Qingliang Liu, Mansour K. Gatasheh, Anis Ahamed, Fei Shao
Journal of Biochemical and Molecular Toxicology.2025;[Epub] CrossRef
Targeting sirtuin 1/nuclear factor erythroid 2-related factor 2/tumor necrosis factor-α pathway to modulate hepatic ischemia reperfusion-induced injury
Mina Thabet Kelleni, Walaa Yehia Abdelzaher, Marly Adly, Mina Ezzat Attya, Michael A Fawzy, Mohamed Abdellah Ibrahim
World Journal of Hepatology.2025;[Epub] CrossRef
Defying Damage: Insights into Ischemic Reperfusion Injury in Liver Transplantation
V. U. Lakshmi, S. Rajalakshmi, Aswathy Regunath, Gowri Parvathi R. Nair, M. Mohammed Riyas, M. P. Narmadha, Dinesh Balakrishnan
Indian Journal of Transplantation.2025; 19(4): 405. CrossRef
Thymoquinone-loaded self-nano-emulsifying drug delivery system against ischemia/reperfusion injury
Badr Bahloul, Roua Chaabani, Yosri Zahra, Nesrine Kalboussi, Jamil Kraiem, Souad Sfar, Nathalie Mignet, Hassen ben Abdennebi
Drug Delivery and Translational Research.2024; 14(1): 223. CrossRef
Modafinil lightens apoptosis and inflammatory response in hepatic ischemia‐reperfusion injury through inactivation of TLR9/Myd88/p38 signaling
Tairan Zhang, Xidong Wang
Drug Development Research.2024;[Epub] CrossRef
Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: The role of oxidative stress and therapeutic approaches
Joseph George, Yongke Lu, Mutsumi Tsuchishima, Mikihiro Tsutsumi
Redox Biology.2024; 75: 103258. CrossRef
Recent advances in fluorescent probes for ATP imaging
Chen Zhang, Guanzhao Wu
Talanta.2024; 279: 126622. CrossRef
Reversible Fluorescent Probes for Dynamic Imaging of Liver Ischemia-Reperfusion Injury
Wen Zhang, Jihong Liu, Ping Li, Xin Wang, Bo Tang
Accounts of Chemical Research.2024; 57(17): 2594. CrossRef
Flavonoids as therapeutics for myocardial ischemia-reperfusion injury: a comprehensive review on preclinical studies
Vipin Kumar Verma, Priya Bhardwaj, Vaishali Prajapati, Avantika Bhatia, Sayani Purkait, Dharamvir Singh Arya
Laboratory Animal Research.2024;[Epub] CrossRef
ZLN005, a PGC-1α Activator, Protects the Liver against Ischemia–Reperfusion Injury and the Progression of Hepatic Metastases
Celine Tohme, Tony Haykal, Ruiqi Yang, Taylor J. Austin, Patricia Loughran, David A. Geller, Richard L. Simmons, Samer Tohme, Hamza O. Yazdani
Cells.2024; 13(17): 1448. CrossRef
Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer’s Disease: The Potential Role of a Novel Nano-Compound—The Transdermal Glutathione–Cyclodextrin Complex
Ray Yutani, Vishwanath Venketaraman, Nisar Sheren
Antioxidants.2024; 13(9): 1106. CrossRef
Fluorescent probes for sensing peroxynitrite: biological applications
Yan Yang, Jinting Shang, Yiyuan Xia, Yuran Gui
Redox Report.2024;[Epub] CrossRef
An update on the molecular mechanism and pharmacological interventions for Ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy
Bin Tang, Zhijian Luo, Rong Zhang, Dongmei Zhang, Guojun Nie, Mingxing Li, Yan Dai
Cellular Signalling.2023; : 110665. CrossRef
Unveiling the Crucial Roles of O2•–and ATP in Hepatic Ischemia–Reperfusion Injury Using Dual-Color/Reversible Fluorescence Imaging
Jihong Liu, Wen Zhang, Xin Wang, Qi Ding, Chuanchen Wu, Wei Zhang, Luling Wu, Tony D. James, Ping Li, Bo Tang
Journal of the American Chemical Society.2023; 145(36): 19662. CrossRef
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation
Kenneth J. Dery, Jerzy W. Kupiec-Weglinski
Current Opinion in Organ Transplantation.2022; 27(5): 424. CrossRef
Isolongifolene alleviates liver ischemia/reperfusion injury by regulating AMPK-PGC1α signaling pathway-mediated inflammation, apoptosis, and oxidative stress
Jinjin Li, Jie Li, Hongbo Fang, Hang Yang, Tianchun Wu, Xiaoyi Shi, Chun Pang
International Immunopharmacology.2022; 113: 109185. CrossRef
Molecularly Designed Ion-Imprinted Nanoparticles for Real-Time Sensing of Cu(II) Ions Using Quartz Crystal Microbalance
Nihan Aydoğan, Gülgün Aylaz, Monireh Bakhshpour, Tugba Tugsuz, Müge Andaç
Biomimetics.2022; 7(4): 191. CrossRef

Case reports

Gastroenterology and Hepatology
Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report: Young Joo Park, Hyun Young Woo, Moon Bum Kim, Jihyun Ahn, Jeong Heo; J Yeungnam Med Sci. 2022;39(3):256-261. Published online August 10, 2021; DOI: https://doi.org/10.12701/yujm.2021.01151

10,285 View
125 Download
5 Web of Science
6 Crossref

Abstract PDF Supplementary Material

Sarcoidosis often involves the liver. However, primary hepatic sarcoidosis confined to the liver without evidence of systemic involvement is rare. We report the case of a 37-year-old man with hepatic sarcoidosis who initially presented with elevated liver enzymes and suspicious cirrhotic nodules on computed tomography. The patient had cirrhosis but did not have portal hypertension. Based on the initial histopathologic finding of chronic granulomatous inflammation and the common clinical characteristics of sarcoidosis, he was initially diagnosed with primary biliary cholangitis, and his daily dosage of ursodeoxycholic acid was increased to 900 mg. After 14 months of treatment, his total serum bilirubin concentration was 10.9 mg/dL (upper normal limit, 1.2 mg/dL). Additionally, a transjugular liver biopsy revealed multiple noncaseating granulomas. He was diagnosed with primary hepatic sarcoidosis involving the lungs, heart, spleen, kidneys, and skin. Treatment with methylprednisolone was initiated. Two weeks later, he was started on azathioprine, and the dose of steroid was simultaneously reduced. These findings indicate the importance of including hepatic sarcoidosis as a possible diagnosis in patients with elevated liver enzymes or cryptogenic cirrhosis.

Citations

Citations to this article as recorded by

Hepatic Sarcoidosis Mimicking a Metastatic Tumor
Naohiro Nakamura, Yoshiki Matsuno, Kazunori Aoi, Hisashi Kosaka, Sanshiro Kobayashi, Yu Takahashi, Tomomitsu Tahara, Yuri Noda, Koji Tsuta, Makoto Naganuma
Internal Medicine.2025; 64(16): 2439. CrossRef
Liver biopsy as a useful diagnostic tool for hepatic sarcoidosis: A case report
Kenrei Uehara, Tatsuo Kanda, Shuhei Arima, Mai Totsuka, Masayuki Honda, Ryota Masuzaki, Reina Sasaki‑tanaka, Naoki Matsumoto, Masahiro Ogawa, Hirofumi Kogure
Medicine International.2024;[Epub] CrossRef
Navigating Challenges in a Case of Unusual Hepatic and Pulmonar Sarcoidosis: A Comprehensive Clinical Journey
André Gonçalves, Diogo Simas, Plácido Gomes, Carina Leal, Catarina Atalaia-Martins, Helena Vasconcelos
GE - Portuguese Journal of Gastroenterology.2024; : 1. CrossRef
The clinical management of hepatic sarcoidosis: A systematic review
Ram Prasad Sinnanaidu, Vikneshwaran Chandra Kumar, Ranita Hisham Shunmugam, Sanjiv Mahadeva
JGH Open.2024;[Epub] CrossRef
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment
Salvatore Nicolosi, Maria Chernovsky, Darina Angoni, Michael Hughes, Giulia Bandini, Zsuzsanna McMahan, Marta Maggisano, Francesco Salton, Lucrezia Mondini, Mariangela Barbieri, Gianluca Screm, Marco Confalonieri, Elisa Baratella, Paola Confalonieri, Barb
Pharmaceuticals.2024; 17(9): 1106. CrossRef
An Incidental Case of Sarcoidosis in a Young Male Patient Presenting With Symptomatic Chronic Cholecystitis
Kelsey A Clabby, Yelena Piazza, Vladimir Neychev
Cureus.2024;[Epub] CrossRef

Radiology, Radiotherapy & Diagnostic Imaging
Multilocular cystic hemangioma of the liver mimicking mucinous cystic neoplasm: a case report: Nam Kyung Lee, Suk Kim, Seung Baek Hong, So Jeong Lee, Hyung Il Seo; J Yeungnam Med Sci. 2022;39(1):53-57. Published online April 7, 2021; DOI: https://doi.org/10.12701/yujm.2021.00969

12,809 View
113 Download
2 Web of Science
2 Crossref

Abstract PDF

Hepatic hemangiomas infrequently exhibit atypical imaging features, which may cause diagnostic confusion with hepatic malignancies and lead to unnecessary surgery. We report a rare case of multilocular cystic hemangioma of the liver mimicking a mucinous cystic neoplasm of the liver in a 48-year-old female, focusing on computed tomography and magnetic resonance imaging features and their differential diagnosis.

Citations

Citations to this article as recorded by

Non-infectious Hepatic Cystic Lesions: A Narrative Review
Adem Ceri, Andreas Busse-Coté, Delphine Weil, Eric Delabrousse, Vincent Di Martino, Paul Calame
Current Medical Imaging Formerly Current Medical Imaging Reviews.2025;[Epub] CrossRef
Case series multilocular cystic hemangioma of the liver: Three cases and literature review
Chunmiao Liang, RiSheng Yu, Liuhong Wang, Ying Chen
Medicine.2024; 103(33): e39287. CrossRef

Gastroenterology and Hepatology
Gastric cancer and adenomatous colorectal polyp concomitant with pyogenic liver abscess and bacteremia: Min Kyu Kang, Hee Jung Kwon, Min Cheol Kim; Yeungnam Univ J Med. 2020;37(3):246-249. Published online April 10, 2020; DOI: https://doi.org/10.12701/yujm.2020.00094

7,377 View
105 Download

Abstract PDF: Synchronous gastric cancer and adenomatous colorectal polyp in patients with Klebsiella pneumoniae-induced pyogenic liver abscess (KP-PLA) and bacteremia is a rare presentation. A 58-year-old man with a 6-month history of diabetes mellitus (DM) presented with febrile sensation and dull abdominal pain in the right upper quadrant of the abdomen. Subsequent to laboratory test results and abdominal computed tomography findings, KP-PLA with bacteremia was diagnosed. After intravenous antibiotic administration, his symptoms improved, and upper endoscopy and colonoscopy were performed to evaluate the cause of KP-PLA. Biopsy specimens of the prepyloric anterior wall revealed a moderately differentiated adenocarcinoma. Endoscopic mucosal resection of the colon revealed high-grade dysplasia. Early gastric cancer (EGC) and adenomatous colorectal polyps with high-grade dysplasia concomitant with KP-PLA and bacteremia were diagnosed in our patient who had DM. Intravenous antibiotic treatment for KP-PLA, subtotal gastrectomy for EGC, and colonoscopic mucosal resection for the colon polyp were performed. After 25 days of hospitalization, subtotal gastrectomy with adjacent lymph node dissection was performed. Follow-up ultrasound imaging showed resolution of the abscess 5 weeks post-antibiotic treatment, as well as no tumor metastasis. Upper gastrointestinal endoscopy and colonoscopy should be performed to evaluate gastric cancer in patients with PLA or bacteremia, accompanied with DM or an immunocompromised condition.

Review article

Gastroenterology and Hepatology
Drug-induced liver injury: Jeong Ill Suh; Yeungnam Univ J Med. 2020;37(1):2-12. Published online August 27, 2019; DOI: https://doi.org/10.12701/yujm.2019.00297

25,864 View
466 Download
30 Crossref

Abstract PDF

Drug-induced liver injury (DILI), including herbal and dietary supplement hepatotoxicity, is often passed lightly; however, it can lead to the requirement of a liver transplant or may even cause death because of liver failure. Recently, the American College of Gastroenterology, Chinese Society of Hepatology and European Association for the Study of the Liver guidelines for the diagnosis and treatment of DILI have been established, and they will be helpful for guiding clinical treatment decisions. Roussel Uclaf Causality Assessment Method scoring is the most commonly used method to diagnose DILI; however, it has some limitations, such as poor validity and reproducibility. Recently, studies on new biomarkers have been actively carried out, which will help diagnose DILI and predict the prognosis of DILI. It is expected that the development of new therapies such as autophagy inducers and various other technologies of the fourth industrial revolution will be applicable to DILI research.

Citations

Citations to this article as recorded by

Interpretable machine learning enables early and accurate detection of drug‐induced liver injury: A multicenter study with real‐world clinical translation
Jingyi Ling, Shian Zhang, Jun Lin, Zhengju Xu, Runcheng Xu, Qian Lv, Kaixiang Zhang, Sheng Liu, Jie Guo, Cheng Hua, Yin Jia, Xiaoyu Xu, Kun Qian, Shanrong Liu
Interdisciplinary Medicine.2026;[Epub] CrossRef
Retrospective Analysis of Liver Enzyme Changes in Peripheral Facial Palsy Patients Treated with Herbal Medicine and High-Dose Prednisolone
Hyun-Seob Park, Si-Hun Kim, Ha-Jun Yoon, Geun-Mo Kim, Kyung-Won Ha, Ji-Yoon Won, Byun-Woo Son, Jong-Cheol Seo, Shin-Young Kim, Cheol-Hong Kim, Hyun-Min Yoon
Journal of Acupuncture Research.2026;[Epub] CrossRef
Kratom Consumption Associated With Herb-Induced Liver Injury and a Pharmacokinetic Interaction: A Case Report
Samantha Gnanasegaram, Corneliu N Stanciu
Cureus.2026;[Epub] CrossRef
In vitro and in silico evaluation of synthetic compounds derived from bi-triazoles against asexual and sexual forms of Plasmodium falciparum
Leandro do Nascimento Martinez, Minelly Azevedo da Silva, Saara Neri Fialho, Marcinete Latorre Almeida, Amália dos Santos Ferreira, Aurileya de Jesus Gouveia, Welington da Silva Paula do Nascimento, Ana Paula de Azevedo dos Santos, Norton Rubens Diunior L
Malaria Journal.2025;[Epub] CrossRef
Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents
Ahmed K. Saleh, Thanaa A. El-Masry, Aya H. El-Kadem, Nada A. Ashour, Nageh A. El-Mahdy
Future Journal of Pharmaceutical Sciences.2025;[Epub] CrossRef
A case report of liver failure caused by Tetrastigma hemsleyanum Diels et Gilg: A rare case report and literature review
Yan Liu, Xia Zhou, Qiong-Fen Wang, Ming-Wei Liu
Medicine.2025; 104(13): e42059. CrossRef
FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury
Yijie Cheng, Yuxin Yang, Yan Su, Ruihuan Chen, Da Qian, Jingyuan Xu
Scientific Reports.2025;[Epub] CrossRef
Risks of hepatotoxicities during the intensive phase of tuberculosis treatment: A hospital-based case control study
Khanaphan Kemmarak, Bhunyabhadh Chaimay, Somkiattiyos Woradet
Asian Pacific Journal of Tropical Medicine.2025; 18(10): 451. CrossRef
Tocotrienol as a Potential Treatment for Drug-Induced Liver Injury
Nur Syazana Syahira Mohd Norman, Muhammad Ridhuan Al Rasyid Bin Ruslan, Juliana Abd Hamid, Fadhlullah Zuhair Japar Sidik, Nur Azlina Mohd Fahami, Azman Abdullah
International Journal of Pharmacology.2025;[Epub] CrossRef
Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature
Nikola Nikolajevic, Milan Nikolajevic, Ivana Pantic, Bojan Korica, Magdalena Kotseva, Tamara Alempijevic, Dorde Jevtic, Cristian I Madrid, Igor Dumic
Cureus.2024;[Epub] CrossRef
Drug-resistant epilepsy and its selected complications in children
Magdalena Knopek, Joanna Iwanicka, Grzegorz Boryczka
Annales Academiae Medicae Silesiensis.2024; 78: 127. CrossRef
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
Ann Childress, Andrew J. Cutler, Lenard A. Adler, Nicholas Fry, Kobby Asubonteng, Zulane Maldonado-Cruz, Andrea Formella, Jonathan Rubin
CNS Drugs.2024; 38(11): 891. CrossRef
Severe liver injury induced by minocycline in hepatitis B patient: a Case Report
Ran Wang, Yun Li, Xue Xia
Frontiers in Pharmacology.2024;[Epub] CrossRef
Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study
Amal Oweid Almutairi, Mahmoud Zaki El-Readi, Mohammad Althubiti, Yosra Zakariyya Alhindi, Nahla Ayoub, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Safaa Yehia Eid
Tropical Medicine and Infectious Disease.2023; 8(2): 129. CrossRef
Hepatotoxic Components Effect of Chebulae Fructus and Associated Molecular Mechanism by Integrated Transcriptome and Molecular Docking
Liwen Ai, Fan Yang, Wanjun Hu, Liyang Guo, Weixue Liu, Xuexue Xue, Lulu Li, Zunlai Sheng
Molecules.2023; 28(8): 3427. CrossRef
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users
Jonathan D. Vignali, Kevin C. Pak, Holly R. Beverley, Jesse P. DeLuca, John W. Downs, Adrian T. Kress, Brett W. Sadowski, Daniel J. Selig
Journal of Xenobiotics.2023; 13(2): 218. CrossRef
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms
Devaraj Ezhilarasan
Drug Metabolism Reviews.2023; 55(3): 239. CrossRef
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use
Rolf Teschke, Gaby Danan
International Journal of Molecular Sciences.2023; 24(13): 10855. CrossRef
Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity
Siyun Yang, Supratik Kar
Artificial Intelligence Chemistry.2023; 1(2): 100011. CrossRef
Rifampicin-induced ER stress and excessive cytoplasmic vacuolization instigate hepatotoxicity via alternate programmed cell death paraptosis in vitro and in vivo
KM Kainat, Mohammad Imran Ansari, Nuzhat Bano, Pankaj Ramji Jagdale, Anjaneya Ayanur, Mahadeo Kumar, Pradeep Kumar Sharma
Life Sciences.2023; 333: 122164. CrossRef
Establishment of a Stable Acute Drug-Induced Liver Injury Mouse Model by Sodium Cyclamate
Quan Zhou, Zhongtian Peng, Xialing Huang
Journal of Inflammation Research.2022; Volume 15: 1599. CrossRef
Mitochondrial toxicants in Xian-Ling-Gu-Bao induce liver injury by regulating the PI3K/mTOR signaling pathway: an in vitro study
Shujuan Piao, Hongwei Lin, Xia Tao, Wansheng Chen
BMC Complementary Medicine and Therapies.2022;[Epub] CrossRef
Kratom-Induced Liver Injury: A Case Series and Clinical Implications
Mahesh Botejue, Gurjot Walia, Omar Shahin, Jyotsna Sharma, Rasiq Zackria
Cureus.2021;[Epub] CrossRef
Colestasis inducida por anabólicos: reporte de caso y revisión de la literatura
Diana Lizeth Cabrera-Rojas, Juliana Soto-Cardona, Jorge Luis Toro-Molina, Juan Camilo Pérez-Cadavid, Juan Ignacio Marín-Zuluaga
Hepatología.2021; : 273. CrossRef
Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski
Pharmacological Reports.2021; 73(5): 1427. CrossRef
Prediction of Drug-Induced Liver Toxicity Using SVM and Optimal Descriptor Sets
Keerthana Jaganathan, Hilal Tayara, Kil To Chong
International Journal of Molecular Sciences.2021; 22(15): 8073. CrossRef
Five Constituents Contributed to the Psoraleae Fructus-Induced Hepatotoxicity via Mitochondrial Dysfunction and Apoptosis
Zhaojuan Guo, Pin Li, Chunguo Wang, Qianjun Kang, Can Tu, Bingqian Jiang, Jingxuan Zhang, Weiling Wang, Ting Wang
Frontiers in Pharmacology.2021;[Epub] CrossRef
Changes in Liver Function Test Results after Korean Medicine Treatment in Patients of a Korean Medicine Hospital: A Retrospective Chart Review
Min Young Yim, Han Byeol Park, Jae Soo Kim, Hyun Jong Lee, Sung Chul Lim, Yun Kyu Lee
Korean Journal of Acupuncture.2021; 38(4): 275. CrossRef
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases
Rolf Teschke, Yun Zhu, Jing Jing
Journal of Clinical and Translational Hepatology.2020; 8(2): 200. CrossRef
Embarazo y lesión hepática inducida por medicamentos. Reporte de un caso y revisión de la literatura
Christian Labrador-López, Martín Garzón-Olarte, Rodrigo Daza-Fernández, Julián Martínez-Marín, Jorge Lizarazo-Rodríguez, Juan Carlos Molano-Villa, Juan Carlos Marulanda-Gómez, Mario Rey-Tovar
Hepatología.2020; : 157. CrossRef

Case report

Gastroenterology and Hepatology
Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor: Min Kyu Kang, Heon Ju Lee, Joon Hyuk Choi; Yeungnam Univ J Med. 2019;36(2):155-158. Published online January 21, 2019; DOI: https://doi.org/10.12701/yujm.2019.00115

8,748 View
98 Download
4 Crossref

Abstract PDF

Imatinib mesylate is currently used as the first-line treatment for metastatic gastrointestinal stromal tumors (GISTs). Imatinib-induced hepatotoxicity in patients with GIST is very rare. Its features vary from subclinical elevation of serum aminotransferase to clinically apparent acute hepatitis, which is associated with immunologic reactions. Imatinib-induced hepatotoxicity with autoimmune-like features can be treated by the discontinuation of imatinib mesylate and the administration of oral steroids. Here, we report a case of late-onset imatinib-induced hepatitis with autoimmune-like features in a patient with metastatic GIST, which was improved by oral corticosteroids.

Citations

Citations to this article as recorded by

Ibrutinib-Associated Liver Injury in a Patient with Chronic Lymphocytic Leukemia: Clinical Course and Therapeutic Approach
Antonio Frolli, Guido Parvis, Martina Bullo, Selene Grano, Giovanni Fornari, Valentina Bonuomo, Daniela Cilloni, Carmen Fava
Hematology Reports.2025; 17(6): 69. CrossRef
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review
Mansour Tobaiqy, Nawal Helmi, Katie MacLure, Sylvia Saade
International Journal of Clinical Pharmacy.2024; 46(2): 368. CrossRef
Investigation of the role of NLRP3 inflammasome activation in new-generation BCR-ABL1 tyrosine kinase inhibitors-induced hepatotoxicity
Ege Arzuk
Toxicology Letters.2024; 400: 71. CrossRef
Antioxidant-Based Preventive Effect of Phytochemicals on Anticancer Drug-Induced Hepatotoxicity
Ji Eon Park, Chi-Hoon Ahn, Hyo-Jung Lee, Deok Yong Sim, Su Yeon Park, Bonglee Kim, Bum Sang Shim, Dae Young Lee, Sung-Hoon Kim
Antioxidants & Redox Signaling.2023; 38(16-18): 1101. CrossRef

Case Reports

Obstetrics, Gynecology, and Reproductive Medicine
Successful delayed-interval delivery performed 128 days after the vaginal delivery of the first fetus in a twin pregnancy: Yu-Jin Koo; Yeungnam Univ J Med. 2018;35(1):135-139. Published online June 30, 2018; DOI: https://doi.org/10.12701/yujm.2018.35.1.135

10,051 View
88 Download
1 Crossref

Abstract PDF

There has been a significant increase in the number of multiple pregnancies that are associated with a high risk of preterm delivery among Korean women. However, to date, delayed-interval delivery in women with multiple pregnancy is rare. We report a case of delayed-interval delivery performed 128 days after the vaginal delivery of the first fetus in a dichorionic diamniotic twin pregnancy. The patient presented with vaginal leakage of amniotic fluid at 16 weeks of gestation and was diagnosed with a preterm premature rupture of membranes. Three days later, the first twin was delivered, but the neonate died soon after. The second twin remained in utero, and we decided to retain the fetus in utero to reduce the morbidity and mortality associated with a preterm birth. The patient was managed with antibiotics and tocolytics. Cervical cerclage was not performed. The second twin was delivered vaginally at 34 weeks and 5 days of gestation, 128 days after the delivery of the first-born fetus. This neonate was healthy and showed normal development during the 1-year follow-up period. Based on our experience with this case, we propose that delayed-interval delivery may improve perinatal survival and decrease morbidity in the second neonate in highly selected cases.

Citations

Citations to this article as recorded by

Cervical Cerclage at 17 Gestational Weeks for Delayed‐Interval Delivery at 15 and 27 Weeks of Gestation in a Dichorionic Twin Pregnancy: A Case Report
Motomu Suzuki, Toshiyuki Itai, Ryosuke Shindo, Nozomi Maruiwa, Sayaka Suzuki, Natsumi Ono, Azusa Tochio, Kazunori Mukaida, Soichiro Obata, Etsuko Miyagi, Shigeru Aoki
Journal of Obstetrics and Gynaecology Research.2026;[Epub] CrossRef

Gastroenterology and Hepatology
Simultaneous chylothorax and chylous ascites: Tae Soo Jang, In Beom Jeong, Do Yeun Cho, Sung Ju Kang, Oh Jung Kwon; Yeungnam Univ J Med. 2017;34(2):265-269. Published online December 31, 2017; DOI: https://doi.org/10.12701/yujm.2017.34.2.265

3,421 View
7 Download

Abstract PDF: Chylothorax or chylous ascites are rare manifestations of liver cirrhosis. We report a rare case of simultaneous chylothorax and chylous ascites in a patient with hepatitis B virus-related liver cirrhosis. A 76-year-old woman was referred to our hospital with a pleural effusion on her right side. She had no history of recent medical procedures, trauma or tumor. There was no evidence of mass or thoracic duct obstruction in a computed tomography scan. Pleural fluid and ascites were confirmed as chylothorax and chylous ascites by chemistry analysis. Despite thorough conservative care, there was no improvement. Pleurodesis was planned, but hepatic encephalopathy developed suddenly and she did not recover.

Gastroenterology and Hepatology
Budd-Chiari syndrome with antiphospholipid syndrome and systemic lupus erythematosus in a patient with Klinefelter's syndrome: Mingee Lee, Jin Young Huh, Ji Hyang Lee, Sun myoung Kang, Jae Yong Lee, Oh Chan Kwon, Eun Na Kim, Jihun Kim, Danbi Lee; Yeungnam Univ J Med. 2017;34(2):260-264. Published online December 31, 2017; DOI: https://doi.org/10.12701/yujm.2017.34.2.260

3,481 View
9 Download

Abstract PDF: Klinefelter's syndrome is the most common congenital abnormality that causes primary hypogonadism. It is associated with diseases that predominantly affect women, such as systemic lupus erythematosus (SLE), and it can sometimes cause veno-occlusive disease. We experienced a case of Budd-Chiari syndrome (BCS) in a 33-year-old man with Klinefelter's syndrome presented with hematemesis and edema in both lower extremities. The clinical and laboratory findings were compatible with SLE, antiphospholipid syndrome, and BCS. To the best of our knowledge, this is the first case report to describe a simultaneous presentation of these four clinical syndromes in a single patient.

Gastroenterology and Hepatology
Amebic liver abscesses resulting in diagnosis of human immunodeficiency virus infection: Seok Weon Kim, Hyeok Choon Kwon, Seung Woo Nam, Jong Kyung Choi, Joo Won Chung, Dong Won Jang, Soo Yoen Park; Yeungnam Univ J Med. 2017;34(1):96-100. Published online June 30, 2017; DOI: https://doi.org/10.12701/yujm.2017.34.1.96

2,721 View
14 Download

Abstract PDF: Amebic liver abscess (ALA) is the most common extraintestinal manifestation of amebiasis. Amebiasis, a parasitic infection caused by Entamoeba histolytica, used to be a prevalent protozoan disease in Korea, however, with an improving sanitary system, it has been among very uncommon etiology of liver abscess. A recent report suggested that ALA is an emerging parasitic infection in human immunodeficiency virus (HIV)-infected patients even in areas where the disease is not endemic and recommended HIV screening in patients in areas where ALA is not endemic, particularly those without history of travel to a disease-endemic area. We report on two patients who were admitted for treatment of ALA and then diagnosed as HIV infection. We also reviewed the etiology and characteristics of ALA in our hospital during the last 5 years.

Gastroenterology and Hepatology
Massive bleeding from a rectal Dieulafoy lesion in a patient with alcoholic cirrhosis: Young Hoon Choi, Jong Ryeol Eun, Jae Ho Han, Hyun Lim, Jung A Shin, Gun Hwa Lee, Seung Hee Lee; Yeungnam Univ J Med. 2017;34(1):88-90. Published online June 30, 2017; DOI: https://doi.org/10.12701/yujm.2017.34.1.88

3,349 View
10 Download

Abstract PDF: Although Dieulafoy lesion can occur in any part of the gastrointestinal tract, its occurrence in the rectum is rare. Rectal Dieulafoy lesions have been associated with advanced age, renal failure, burns, liver transplantation and cirrhosis. Here, we report on a case of massive bleeding from a rectal Dieulafoy lesion after lung decortication surgery in a 57-year-old male patient with alcoholic cirrhosis. Although rare, a rectal Dieulafoy lesion should be included in the differential diagnosis of massive lower gastrointestinal bleeding in a patient with cirrhosis.

Gastroenterology and Hepatology
A Case of Recurrent Liver Abscess Due to Choledochoduodenal Fistula.: Jun Ho Hur, Sun Taek Choi, Min Su Sohn, Ji Eun Lee, In Hee Chung, Sung Ho Ki; Yeungnam Univ J Med. 2013;30(1):39-42. Published online June 30, 2013; DOI: https://doi.org/10.12701/yujm.2013.30.1.39

2,618 View
2 Download

Abstract PDF: Cholelithiasis, duodenal ulcer, duodenal perforation and tumor invasion may lead to choledochoduodenal fistula (CDF). CDF often has no specific symptoms and may be incidentally detected in an upper gastrointestinal radiographic study or endoscopy; but in some cases, it may be accompanied by recurrent cholangitis and liver abscess. In this paper, a case of recurrent liver abscess caused by CDF is reported. A 62-year-old female was admitted to the authors' hospital because of right upper quadrant pain and fever. The abdominal computed tomography showed a liver abscess in the right lobe. A duodenal fistulous orifice was detected with endoscopy, and a contrast was injected through the duodenal orifice using a catheter under fluoroscopy. The injection of the contrast revealed a fistulous track between the duodenal bulb and the common hepatic duct. In fistulas complicated by recurrent liver abscess, surgery or medical management may be needed. The CDF in this case study was treated via endoscopic clipping.

Review

Pathology and Forensic Medicine
Combined Hepatocellular-Cholangiocarcinoma: Recent Progress in Pathology and Classification.: Joon Hyuk Choi; Yeungnam Univ J Med. 2011;28(1):1-12. Published online June 30, 2011; DOI: https://doi.org/10.12701/yujm.2011.28.1.1

3,022 View
6 Download
1 Crossref

Abstract PDF

Primary liver carcinomas have been classified into hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma (CHC). CHC is a tumor containing unequivocal, intimately mixed elements of both hepatocellular carcinoma and cholangiocarcinoma. It forms a small but significant proportion of primary liver carcinomas. The origin and pathogenesis of CHC have not been well established. According to the 2010 WHO classification, CHCs are categorized into 2 groups: the classical type and a subtype with stem cell features. This review describes recent progress in pathology and classification of CHC.

Citations

Citations to this article as recorded by

Synchronous Double Primary Hepatic Cancer: Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Jin Ok Kim, Dae Won Jun, Kiseok Jang
The Korean Journal of Gastroenterology.2013; 62(2): 135. CrossRef

Case Reports

Gastroenterology and Hepatology
A Case of Colchicine-Induced Neutropenia in Liver Cirrhosis Patient.: Ho Chan Lee, Heon Ju Lee, Yong Gil Kim, Jae Hyun Park, Sung Joon Kim, Jun Seok Park; Yeungnam Univ J Med. 2009;26(2):125-129. Published online December 31, 2009; DOI: https://doi.org/10.12701/yujm.2009.26.2.125

3,370 View
19 Download

Abstract PDF: Colchicine is an alkaloid that has been used for treating acute gouty arthritis, psoriasis, scleroderma and Behcet's syndrome. Colchicine decreased liver fibrosis in rats with carbon tetrachloride induced cirrhosis and in patients with many liver diseases. Therapeutic oral doses of colchicine may cause nausea, vomiting, abdominal pain and diarrhea. The adverse effect of colchicine associated with the dose is bone marrow suppression, and especially neutopenia. Neutropenia has often been reported in patients have taken an overdose of colchicine. We describe a 64-year-old female liver cirrhosis patient with neutropenia that was induced by a therapeutic dose of colchicine.

Pediatrics, Perinatology, and Child Health
A Case of Liver Abscess in A Child.: Seung Taek Oh, Kwang Hae Choi; Yeungnam Univ J Med. 2008;25(1):72-77. Published online June 30, 2008; DOI: https://doi.org/10.12701/yujm.2008.25.1.72

2,873 View
2 Download
1 Crossref

Abstract PDF

Liver abscess in children is rare in developed countries; the incidence is 25 per 100,000 admissions in USA. Common complications are pleural effusion, empyema, pneumonitis, hepatopleural or hepatobronchial fistula, intraperitoneal or intrapericardiac rupture, septic shock, cerebral amebiasis, etc. These complications may lead to death if the management is delayed. However, recent management results in a mortality of less than 15%. We report a case of liver abscess in a child. He manifested with fever and abdominal pain in the right upper quadrant. On computerized tomography scans, multiple cystic lesions were seen in both lobes of the liver and were 5 to 55 mm in size. In laboratory findings, neutrophilic leukocytosis, peripheral eosinophila, elevated values of ESR, C-reactive protein, and elevated serum AST, ALT, ALP and GGT were detected. Furthermore, we determined the organisms in the blood culture and serum. Blood culture was positive for Streptococcus spp., and amebic indirect hemagglutination antibody titer was increased to 1:512.

Citations

Citations to this article as recorded by

A case of pyogenic liver abscess in a 10-year-old girl
Jung Lim Byun, Sun Hwan Bae, Sang Woo Park
Korean Journal of Pediatrics.2010; 53(5): 666. CrossRef

Original Article

Radiology, Radiotherapy & Diagnostic Imaging
Nonsegmental Abnormal Arterial Attenuation : Transient Hyperperfusion of the Peripheral Zone of the Liver on Arterial Dominant Phase: Won Kyu Park, Jay Chun Chang, Jae Woon Kim; Yeungnam Univ J Med. 2007;24(2 Suppl):S310-318. Published online December 31, 2007; DOI: https://doi.org/10.12701/yujm.2007.24.2S.S310

1,853 View
2 Download

Abstract PDF: Purpose：This study was done to arrange the cases showing temporally hyperperfusion in the periphery of the liver, to check the etiology and mechanism, and to find out the new radiologic role on diffuse liver disease. Materials and Methods：We reviewed 12 cases of showing transient arterial hyperperfusion in the just peripheral portion of the liver on the arterial dominant phase on dynamic CT and the absence of abnormal perfusion between central and peripheral portion on tissue equilibrium phase. We retrospectively analyzed final diagnosis and the presence of main portal vein thrombi, and cavernous transformation.
Results
：Final diagnosis in 12 cases was as follows: diffuse liver disease was in seven cases, pancreatitis in three and pyogenic portal thrombosis in two. Main portal vein thrombosis were detected all cases of pancreatitis and pyogenic portal thrombosis. In seven diffuse liver disease, two cases shown thrombosed, two cases shown normal and the other cases are collapsed. Cavernous transformation was in three cases of pancreatitis and two of diffuse liver disease.
Conclusion
：We think that the causes of this phenomenon maybe as follows: the difference of the hemodynamic compensation mechanism between central and peripheral zone of the liver, presence of microscopic thrombi in peripheral portal branch which cannot be detected by imaging technique, hypercoagulability in portal area, the systematic destruction of terminal portal branch and the development of ectopic portal pathway.

Review

Surgery
Current Status of Liver Transplantation.: Hong Jin Kim; Yeungnam Univ J Med. 2001;18(1):1-12. Published online June 30, 2001; DOI: https://doi.org/10.12701/yujm.2001.18.1.1

2,325 View
6 Download

Abstract PDF: Liver transplantation is widely accepted as an effective therapeutic modality for a variety of irreversible acute and chronic liver disease for which no satisfactory therapy is available. Following the first unsuccessful efforts at human liver transportation in 1963, development of the procedure evolved at first slowly and steadily for 20 years and then rapidly over the past two decades. The growth of liver transplantation was facilitated by the conclusion of the national institutes of health consensus development conference in 1983 that liver transplantation is not an experimental procedure but an effective therapy that deserves broader application. The number of liver transplantations increased 2.4-fold(from 1.713 to 4.058) from 1988 to 1996, but the number of patients on the UNOS(united network of organ sharing) liver list increased 12.1-fold(from 616 to 7,467); as would be expected, the number deaths of listed patients increased 4.9-fold(from 195 to 954). The current supply of donor livers is insufficient to meet this need, and organ donation has been stagnant or increased by only a few percent in recent years. These facts underscore the importance of the appropriate selection of candidates for liver transplantation and the development of operative procedure, such as living donor liver transplant. split liver transplant and auxiliary partial liver transplant.

Case Report

Obstetrics, Gynecology, and Reproductive Medicine
Three cases of symphysis pubis separation associated with delivery.: Jae Hong Ahn, Young Jin Jang, Dong Hyuk Lee, Young Gi Lee, Yoon Ki Park; Yeungnam Univ J Med. 2000;17(1):93-98. Published online June 30, 2000; DOI: https://doi.org/10.12701/yujm.2000.17.1.93

2,410 View
1 Download

Abstract PDF: Symphysis pubis separation is an uncommon but not rare complication of delivery. Characteristic symptoms of symphyseal separation include suprapubic pain and tenderness which radiate to the back or legs, difficult ambulation, and bladder dysfunction. Clinical history, presenting symptoms, and response to therapy are sufficient to make the diagnosis, although radiographic documentation of symphyseal separation by x-ray or ultrasound are frequently used to confirm the diagnosis. The underlying etiology of symptomatic symphyseal separation has not been fully elucidated. Associations with macrosomia, pathological joint loosening, and increased force placed on the pelvic ring have been suggested as possible etiologies. Conservative therapy, including bed rest, pelvic binders, ambulation devices, and mild analgesics usually result in complete recovery within 4-16 weeks. Our experience of three cases of peripartum symphysis pubis separation delivered from 1998 to 1999 were reviewed with related articles.

Original Article

Gastroenterology and Hepatology
Detection of Serum Hepatitis B Virus DNA According to HBV Markers in Chronic Hepatitis B Liver Disease.: Dong Jun Lee, Jin Su Choi, Joon Hwan Kim, Heon Ju Lee; Yeungnam Univ J Med. 1997;14(1):155-167. Published online June 30, 1997; DOI: https://doi.org/10.12701/yujm.1997.14.1.155

2,311 View
2 Download

Abstract PDF: The identification of serum HBV DNA is very important for the assessment of the disease activity in persistent infection, for the evaluation of the infectivity of an individuals blood. The dot blot, however, has limited sensitivity and sometimes inconsistent with other serological markers and clinical settings. Using the most important recent advance in molecular biology, the polymerase chain reaction(PCR), specific DNA sequences can be amplified more than a million-fold in a few hours and with this technique the detection of the extreme low level of DNA is possible. This study was to determine sensitivity of the PCR for the detection of serum HBV DNA in comparison with dot blot analysis and to investigate the serum HBV DNA status and clinical significance of PCR in patients with chronic HBsAg positive liver disease. The subjects of this study were 17 patients with asymptomatic HBsAg carriers(9 HBeAg positive patients, 8 anti-HBe positive patients), 91 chronic hepatitis B(50 HBeAg positive patients, 41 anti-HBe positive patients), 57 liver cirrhosis(21 HBeAg positive patients, 36 anti-HBe positive patients), 27 hepatocellular carcinoma(10 HBeAg positive patients, 17 anti-HBe positive patients). The results were summerized as following; The detection rates of HBV DNA by dot blot, PCR were 58.9%, 72.2% in HBeAg positive patients, 34.3%, 53.9% in anti-HBe positive patients. The detection rates of HBV DNA by PCR in HBeAg negative patients were 25.0% in asymptomatic HBsAg carriers, 61.0% in chronic hepatitis B, 52.8% in liver cirrhosis, 52.9% in hepatocellular carcinoma. The positive rate for HBV DNA is a significant difference between HBeAg positive and negative asymptomatic HBsAg carriers, but not significantly difference in other groups. In conclusions, this study confirmed that the PCR is much more sensitive than the dot blot analysis in detecting the HBV DNA in the sera of patients with chronic liver disease. The presence of HBV DNA in the serum was detected by PCR with higher sensitivity and it suggested that active viral replication is still going on in most patients with chronic HBsAg positive liver disease irrespective of HBeAg/anti-HBe status, and PCR may be used as a prognostic factor in asymptomatic HBsAg carriers.

Case Report

Oncology and Cancer Research
A Case of Rhabdomyosarcoma in the Liver.: Dong Jun Lee, Ji Sung Yoon, Joon Hwan Kim, Chan Won Park, Jeong Ill Suh, Heon Ju Lee, Ki Kweon Kim; Yeungnam Univ J Med. 1996;13(2):360-366. Published online December 31, 1996; DOI: https://doi.org/10.12701/yujm.1996.13.2.360

2,121 View
4 Download

Abstract PDF: Pure primary hepatic rhabdomyosarcoma in adult is very uncommon. There have been only five previous case of primary rhabdomyosarcoma of the adult liver. A case of hepatic ihabdomyosarcoma was diagnosed in a 52 year-old female. She was admitted to the hospital due to the epigastric pain and weight loss. A CT scan of the abdomen showed a large hypodense mass with focal calcification occupies most of the both lobes of the liver. The liver biopsy showed massive liver tumor composed entirely of oval shaped cells showing light microscopic and immunohistochemical evidence of rhabdomyoblastic differentiation. We report a case of hepatic rhabdomyosarcoma with review of literature.

Original Article

Gastroenterology and Hepatology
Subtypes of Hepatitis B Surface Antigen Among Chronic Liver Disease.: Hee Soon Cho, So Yeo Kim, Chae Hoon Lee, Kyung Dong Kim, Chung Sook Kim; Yeungnam Univ J Med. 1996;13(2):272-278. Published online December 31, 1996; DOI: https://doi.org/10.12701/yujm.1996.13.2.272

2,251 View
3 Download

Abstract PDF: Four subtypes of hepatitis B surface antigen are useful in the epidemiologic studies of the route of virus transmission and clinical significance of simultaneous occurance of hepatitis B surface antigen and antibody to hepatitis B surface antigen in the same serum as well as useful marker for population migration. The sera were obtained from 214 HBs Ag positive patients who are diagnosed as chronic liver disease and following up in the Yeungnam university hospital. The subtypes were determined by solid-phase sandwich EM using monoclonal antibodies. Among 214 specimens, the subtype adr was 93.9%, adw was 2.8%, ayr was 0.9%, ar was 0.9%, adwr was 1.4% and ayw was not detected. There were no correlation between subtype pattern and disease. In summary, the subtype adr was prominent in our study and the difference of subtype pattern by severity of disease was not significant. However, to determine the prognostic value of HBs Ag subtype and relationship between subtype and disease progression, long-term follow up will be needed.

Case Report

Gastroenterology and Hepatology
Focal Nodular Hyperplasis in Liver.: Ki Ho Seong, Jae Ho Cho, Jae Chun Chang; Yeungnam Univ J Med. 1995;12(2):400-404. Published online December 31, 1995; DOI: https://doi.org/10.12701/yujm.1995.12.2.400

2,122 View
1 Download

Abstract PDF: Focal nodular hyperplasia is a benign hepatic tumor mainly composed of nodules of hepatocytes and Kupffer cells separated by fibrous septa. In general, it is difficult to differentiate focal nodular hyperplasia and hepatocellular carcinoma on ultrasonography, conventional CT(computerized tomography), and angiography. But IV bolus CT is of particular value in the diagnosis of focal nodular hyperplasia because it can divide enhanced CT into early and late phase and can characterize tumor vascularity and analyze any intratumoral elements. In our case, it was seen as a hypoechoic mass lesion on ultrasonograpl'hy and hyperdense mass lesion on early-phase IV bolus CF and isodense mass, lesion on late-phase IV bolus CT. On angiography, hypertrophy of the feeding artery and tumor staining were well visualized. The patient underwent operation and the mass was pathologically confirmed to a focal nodular hyperplasia. We report the first case of focal nodular hyperplasia on IV bolus CT in Korea.

Original Articles

Pathology and Forensic Medicine
Effect of phenobarbital pretreatment on the hepatotoxicity of carbon tetrachloride in rat.: Young Soo Byun, Hae Joo Nam, Mi Jin Kim, Dong Suk Kim, Won Hee Choi, Tae Sook Lee; Yeungnam Univ J Med. 1992;9(1):137-148. Published online June 30, 1992; DOI: https://doi.org/10.12701/yujm.1992.9.1.137

2,354 View
3 Download

Abstract PDF: The purpose of this study was to evaluate the influence of phenobarbital (PB) on hepatotoxic effect of carbon tetrachloride (CCI4) which induces centrilobular necrosis in liver. Rats were injected intraperitoneally CCI4 dissolved in olive oil by a dose of 0.4 mg/kg. For change related to PB pretreatment, rats were injected CCI₄ 0.4mg/kg after PB pretreatment. The liver samples were taken in 6, 12, 24, 48, 72 and 120 hours after CCI₄ and/ or PB injection. Extracted liver tissue was examined with light and electron microscopes. The results were summarized as follows: 1. Light microscopic findings: In CCI₄ group, centrilobular necrosis developed from 6 hours after injection, was the most severe in 48 hours, and recovered after 72 hours. In addition to necrosis, fatty change and pale cell change were accompanied. In PB-CCI4 group, necrosis occurred from 6 hours after CCI₄ injection and continued to 72 hours, and the degree of necrosis was more severe than that of CCI₄ group and pale cell change was decreased. 2. Electron microscopic findings: In CCI4 group, the early principal change was clumping and vesicular dilatation of endoplasmic reticulum. In PB-CCI₄ group, the degenerative change of endoplasmic reticulum was aggravated and the mitochondria also revealed severe degenerative change. According to the results, it was revealed that CCI₄ hepatotoxicity primarily began with the damage of endoplasmic reticulum, then damage of other cell organelles and cell necrosis followed, and these cytotoxic effects were aggravated by PB pretreatment.

Pathology and Forensic Medicine
Effects of carbon tetrachloride on structures in hepatocytes following DMN induced hepatotoxicity.: Young Chun Kang, Hae Joo Nam, Dong Suk Kim, Won Hee Choi, Tae Sook Lee; Yeungnam Univ J Med. 1991;8(2):84-94. Published online December 31, 1991; DOI: https://doi.org/10.12701/yujm.1991.8.2.84

2,418 View
2 Download

Abstract PDF: The purpose of this study was to evaluate the influence of high dose carbon tetrachloride (CCI4) on the hepatotoxic effect of dimethylnitrosamine (DMN) which induces acute hemorrhagic necrosis in liver. Rats were injected intraperitoneally DMN dissolved in physiologic saline by a dose of 40 mg/kg. For changes related to CCI⁴ pretreatment, rats were injected intraperitoneally CCI⁴ dissolved in olive oil by a dose of 0.4 mg/kg, and then injected DMN. The livers were extracted from the rats 3, 6, 12, 24, 48, 72, and 120 hours after CCI⁴ and/ or DMN injection. Liver tissues were examined with light and electron microscopes. The results were summarized as follows; Light microscopic findings: Severe centrilobular hemorrhagic necrosis developed from 12 hours after injection of DMN and continued to 120 hours. On injection of DMN after CCI4 pretreatment, Massive necrosis occurred early. But active regenerative changes were produced in 24 hours. In 120 hours, the liver recovered in almost normal appearance. The degree of necrosis in pretreated group was similar to that in DMN injection only, and the time of recovery was faster in pretreated group. Electron microscopic findings: The early change was mainly disorganization of RER in DMN injection, and clumping and vesicular dilatation of ER in injection of CCI4. In pretreatment group, the early change was similar in appearance with CCI4 group, but severer in degree. According to the results, it was revealed that acute toxic effect of DMN was recovered more rapidly in pretreatment group. Thus it was suggested that CCI4 had protective effect in DMN hepatotoxicity.

Case Reports

Surgery
A Human Case of Hepatic Resection for Liver Fascioliasis in Korea.: Hong Jin Kim, Sung Kyun Roh, Min Chul Shim, Koing Bo Kwun, Heun Ju Lee, Jae Chun Chang, Tae Sook Lee; Yeungnam Univ J Med. 1990;7(1):165-171. Published online June 30, 1990; DOI: https://doi.org/10.12701/yujm.1990.7.1.165

2,535 View
2 Download
1 Crossref

Abstract PDF

Human Fasciola hepatica infection is a rare entity involving infestation of the liver and biliary tree with adult flukes, which can result in hepatitis, cirrhos is and biliary tract inflammation, obstruction and lithiasis. The patient had the typical diagnostic tetrad of fever, eosinophilic leukocytosis, tender hepatomegaly and fluke ova in the stools. Treatment consists of Emetine hydrochloride hydrochloride administration for hepatic involvement and common bile duct exploration for removal of flukes, with cholecystectomy for associated cholelithiasis. The combination of medical and surgical therapy can be expected to produce an arrest of this infection. The removed liver revealed eggs of the fasciola species in the intrahepatic bile duct. The clinical history, pathological findings and treatment of this case were described.

Citations

Citations to this article as recorded by

Subcutaneous fascioliasis: a case report
E C Chang, H L Choi, Y W Park, Y Kong, S Y Cho
The Korean Journal of Parasitology.1991; 29(4): 403. CrossRef

Gastroenterology and Hepatology
Liver abscess and septic complications associated with advanced gastric cancer.: Gun Jung Youn, Young Choi, Min Jae Kim, Jae Sin Lee, Ui Won Ko, Yeon Ho Joo; Yeungnam Univ J Med. 2015;32(1):38-41.; DOI: https://doi.org/10.12701/yujm.2015.32.1.38

3,931 View
11 Download
2 Crossref

Abstract PDF

Pyogenic liver abscess with metastatic septic complications is a rare and serious infectious disease if not treated properly. Pyogenic liver abscesses are caused by bacterial, fungal, or parasitic organisms. Escherichia coli used to be the predominant causative agent, but Klebsiella pneumoniae emerged as a major cause in the 1990s. Liver abscesses are caused by hepatic invasion via many routes, such as, the biliary tree, portal vein, hepatic artery, direct extension, or penetrating trauma. Furthermore, diabetes mellitus and malignant conditions are established important risk factors of K. pneumoniae liver abscesses and of septic metastasis, and several recent studies have asserted that K. pneumoniae liver abscess might be a presentation of occult or silent colon cancer. We report a case of K. pneumoniae liver abscess, metastatic septic pulmonary embolism, and endophthalmitis associated with diabetes and advanced gastric cancer.

Citations

Citations to this article as recorded by

Gastric cancer and adenomatous colorectal polyp concomitant with pyogenic liver abscess and bacteremia
Min Kyu Kang, Hee Jung Kwon, Min Cheol Kim
Yeungnam University Journal of Medicine.2020; 37(3): 246. CrossRef
A Case of Advanced Gastric Cancer Concomitant with Pyogenic Liver Abscess in the Patient with Subtotal Gastrectomy
Dong-Hee Park, Nae-Yun Heo, Heon Sa-Kong, Na-Ri Jeong, Su-Jin Jeong, Sung Jin Oh, Kyung Han Nam
The Korean Journal of Gastroenterology.2017; 69(2): 143. CrossRef

Review

Gastroenterology and Hepatology
Cellular origin of liver cancer stem cells.: Jong Ryeol Eun; Yeungnam Univ J Med. 2015;32(1):1-7.; DOI: https://doi.org/10.12701/yujm.2015.32.1.1

3,177 View
31 Download

Abstract PDF: Over several decades, a hierarchical cancer stem cell (CSC) model has been established in development of solid cancers, including hepatocellular carcinoma(HCC). In terms of this concept, HCCs originate from liver CSCs. Clinically HCCs show a wide range of manifestations from slow growth to very aggressive metastasis. One of the reasons may be that liver CSCs originate from different cells. This review describes the basic concept of CSCs and the cellular origin of liver CSCs.

First
Prev
Page of 1
Next
Last

Search